Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
8.61
+0.17 (2.01%)
At close: Sep 18, 2026, 4:00 PM EDT
8.60
-0.01 (-0.12%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 115 employees as of June 30, 2026. The number of employees increased by 10 or 9.52% compared to the same quarter last year.
Employees
115
Change
10
Growth
9.52%
Revenue / Employee
n/a
Profits / Employee
-$789,748
Market Cap
420.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 115 | 10 | 9.52% |
| Mar 31, 2026 | 106 | 10 | 10.42% |
| Dec 31, 2025 | 104 | 15 | 16.85% |
| Sep 30, 2025 | 106 | 24 | 29.27% |
| Jun 30, 2025 | 105 | 23 | 28.05% |
| Mar 31, 2025 | 96 | 15 | 18.52% |
| Dec 31, 2024 | 89 | 8 | 9.88% |
| Sep 30, 2024 | 82 | - | - |
| Jun 30, 2024 | 82 | - | - |
| Mar 31, 2024 | 81 | - | - |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 149 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Larimar Therapeutics | 71 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
ARTV News
- 2 days ago - Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 4 days ago - Artiva Biotherapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 10 days ago - Artiva Biotherapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 11 days ago - Artiva Biotherapeutics provides update on AlloNK data disclosures - TheFly
- 11 days ago - Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026 - GlobeNewsWire
- 17 days ago - Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 6 weeks ago - Artiva Biotherapeutics files $400M mixed securities shelf - TheFly
- 6 weeks ago - Artiva Biotherapeutics reports Q2 EPS (63c), consensus (64c) - TheFly